First Trial of Gene Therapy for Advanced Heart Failure Shows Promising Results
November 10, 2008 by admin · Leave a Comment
Phase I Results Presented at the American Heart Association Scientific Sessions Affirm Safety and Show Promise for Clinical Improvements
NewYork-Presbyterian Hospital/Columbia University Medical Center and Other Study Centers Begin Phase II
New therapy for heart failure
October 15, 2008 by admin · Leave a Comment
During heart failure the body reacts to the production of the hormone aldosterone. Too much aldosterone can stiffen and damage the muscles of the heart. Dutch researcher Luc Roumen has optimised compounds that inhibit the production of this hormone and looked at their optimum dosage. The compounds were manufactured by the companies Schering-Plough and SyMO-Chem BV and a drug patent has been applied for.
